X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (343) 343
Newspaper Article (110) 110
Patent (99) 99
Publication (33) 33
Conference Proceeding (16) 16
Dissertation (8) 8
Book Review (3) 3
Report (3) 3
Magazine Article (2) 2
Book Chapter (1) 1
Reference (1) 1
Streaming Audio (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (111) 111
male (79) 79
female (66) 66
adult (59) 59
middle aged (57) 57
index medicus (56) 56
physics (56) 56
oncology (55) 55
calculating (49) 49
computing (49) 49
counting (49) 49
electric digital data processing (47) 47
aged (46) 46
chemotherapy (33) 33
materials science, multidisciplinary (25) 25
antineoplastic combined chemotherapy protocols - therapeutic use (23) 23
analysis (21) 21
information storage (21) 21
medicine, general & internal (21) 21
neoplasm staging (20) 20
static stores (20) 20
carcinoma, non-small-cell lung - drug therapy (19) 19
lung neoplasms - drug therapy (19) 19
nuclear science & technology (18) 18
aged, 80 and over (17) 17
treatment outcome (16) 16
carcinoma, non-small-cell lung - pathology (14) 14
colorectal cancer (14) 14
electricity (13) 13
nuclear fuel cycle and fuel materials (13) 13
primary health care (13) 13
electric communication technique (12) 12
information storage based on relative movement between recordcarrier and transducer (12) 12
irradiation (12) 12
lung neoplasms - pathology (12) 12
respiratory system (12) 12
uranium (12) 12
adolescent (11) 11
alloys (11) 11
carcinoma (11) 11
chemistry (11) 11
mechanical engineering (11) 11
research (11) 11
survival analysis (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
child (10) 10
cisplatin - administration & dosage (10) 10
dentistry, oral surgery & medicine (10) 10
disease-free survival (10) 10
heating (10) 10
human necessities (10) 10
materials science (10) 10
surgery (10) 10
therapy (10) 10
blasting (9) 9
brennstoff (9) 9
cancer (9) 9
fuels (9) 9
homosexuality (9) 9
lighting (9) 9
prognosis (9) 9
retrospective studies (9) 9
temperature (9) 9
weapons (9) 9
1st-line treatment (8) 8
carcinoma, non-small-cell lung - mortality (8) 8
clinical intelligence (8) 8
combustion engines (8) 8
deoxycytidine - analogs & derivatives (8) 8
drug administration schedule (8) 8
education, medical, graduate (8) 8
foods or foodstuffs (8) 8
foods, foodstuffs, or non-alcoholic beverages, not covered bysubclasses a23b - a23j (8) 8
hot-gas or combustion-product engine plants (8) 8
jet-propulsion plants (8) 8
metallurgy (8) 8
molybdenum (8) 8
mutation (8) 8
nuclear fuel (8) 8
preservation of foods or foodstuffs, in general (8) 8
their preparation or treatment, e.g. cooking, modification ofnutritive qualities, physical treatment (8) 8
their treatment, not covered by other classes (8) 8
article (7) 7
behavior (7) 7
care and treatment (7) 7
enriched uranium (7) 7
fluorouracil (7) 7
follow-up studies (7) 7
gemcitabine (7) 7
general practice - education (7) 7
general tagging of cross-sectional technologies spanning over several sections of the ipc (7) 7
general tagging of new technological developments (7) 7
hematology (7) 7
lung neoplasms - mortality (7) 7
metastasis (7) 7
mining & mineral processing (7) 7
motion pictures (7) 7
nuclear energy (7) 7
oxaliplatin (7) 7
prospective studies (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Ackermann, K.H and Adams, N and Adler, C and Ahammed, Z and Ahmad, S and Allgower, C and Amonett, J and Amsbaugh, J and Anderson, B.D and Anderson, M and Anderssen, E and Arnesen, H and Arnold, L and Averichev, G.S and Baldwin, A and Balewski, J and Barannikova, O and Barnby, L.S and Baudot, J and Beddo, M and Bekele, S and Belaga, V.V and Bellwied, R and Bennett, S and Bercovitz, J and Berger, J and Betts, W and Bichsel, H and Bieser, F and Bland, L.C and Bloomer, M and Blyth, C.O and Boehm, J and Bonner, B.E and Bonnet, D and Bossingham, R and Botlo, M and Boucham, A and Bouillo, N and Bouvier, S and Bradley, K and Brady, F.P and Brandin, A and Brown, R.L and Brugalette, G and Burkes, M and Cadman, R.V and Caines, H and Calderón de la Barca Sánchez, M and Cardenas, A and Carr, L and Carroll, J and Castillo, J and Castro, M and Cebra, D and Chattopadhyay, S and Chen, M.L and Chen, W and Chen, Y and Chernenko, S.P and Cherney, M and Chikanian, A and Choi, B and Chrin, J and Christie, W and Coffin, J.P and Conin, L and Consiglio, C and Cormier, T.M and Cramer, J.G and Crawford, H.J and Danilov, I and Dayton, D and DeMello, M and Deng, W.S and Derevschikov, A.A and Dialinas, M and Diaz, H and DeYoung, P.A and Didenko, L and Dimassimo, D and Dioguardi, J and Drancourt, C and Dietel, T and Draper, J.E and Dunin, V.B and Dunlop, J.C and Eckardt, V and Edwards, W.R and Efimov, L.G and Eggert, T and Emelianov, V and Engelage, J and Eppley, G and Erazmus, B and Etkin, A and Fachini, P and Faine, V and Feliciano, C and Ferenc, D and ... and STAR Collaboration
Nuclear Inst. and Methods in Physics Research, A, ISSN 0168-9002, 2003, Volume 499, Issue 2, pp. 624 - 632
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2010, Volume 127, Issue 1, pp. S1 - S55
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2018, Volume 378, Issue 2, pp. 113 - 125
In 556 patients with previously untreated lung cancer bearing EGFR mutations, osimertinib and the first-generation EGFR inhibitors erlotinib and gefitinib had... 
1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | GEFITINIB | THERAPY | PHASE-III | ACQUIRED-RESISTANCE | OPEN-LABEL | CNS RESPONSE | AZD9291 | CHEMOTHERAPY | ERLOTINIB | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | ErbB Receptors - genetics | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Gefitinib | Lung Neoplasms - genetics | Double-Blind Method | Carcinoma, Non-Small-Cell Lung - genetics | Kaplan-Meier Estimate | Survival Rate | Piperazines - therapeutic use | Carcinoma, Non-Small-Cell Lung - mortality | Piperazines - adverse effects | Disease-Free Survival | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Aged | Erlotinib Hydrochloride - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Protein-Tyrosine Kinases - antagonists & inhibitors | Treatment outcome | Cancer patients | Care and treatment | Lung cancer, Non-small cell | Analysis | Tyrosine | Medical research | Epidermal growth factor receptors | Lung cancer | Clinical trials | Non-small cell lung carcinoma | Oncology | Metastasis | Gene deletion | Patients | Cancer therapies | Clinical outcomes | Chemotherapy | Epidermal growth factor | Clonal deletion | Protein-tyrosine kinase receptors | Protein-tyrosine kinase | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
by Ramalingam, S and Crawford, J and Chang, A and Manegold, C and Perez-Soler, R and Douillard, J.-Y and Thatcher, N and Barlesi, F and Owonikoko, T and Wang, Y and Pultar, P and Zhu, J and Malik, R and Malik Giaccone, R and Della-Fiorentina, S and Begbie, S and Jennens, R and Dass, J and Pittman, K and Ivanova, N and Koynova, T and Petrov, P and Tomova, A and Tzekova, V and Couture, F and Hirsh, V and Burkes, R and Sangha, R and Ambrus, M and Janaskova, T and Musil, J and Novotny, J and Zatloukal, P and Jakesova, J and Klenha, K and Roubec, J and Vanasek, J and Fayette, J and Barlesi, F and Bennouna-Louridi, J and Chouaid, C and Mazières, J and Vallerand, H and Robinet, G and Souquet, P.-J and Spaeth, D and Schott, R and Lena, H and Martinet, Y and Kouri, C.E and Baize, N and Scherpereel, A and Molinier, O and Fuchs, F and Josten, K.M and Manegold, C and Marschner, N and Schneller, F and Overbeck, T and Thomas, M and von Pawel, J and Reck Schuette, M and Hagen, V and Schneider, C.-P and Georgoulias, V and Varthalitis, I and Zarogoulidis, K and Syrigos, K and Papandreou, C and Bocskei, C and Csanky, E and Juhasz, E and Losonczy, G and Mark, Z and Molnar, I and Papai-Szekely, Z and Tehenes, S and Vinkler, I and Almel, S and Bakshi, A and Bondarde, S and Maru, A and Pathak, A and Pedapenki, R.M and Prasad, K and Prasad, S.V.S.S and Kilara, N and Gorijavolu, D and Deshmukh, C.D and John, S and Sharma, L.M and Amoroso, D and Bajetta, E and Bidoli, P and Bonetti, A and De Marinis, F and Maio, M and Passalacqua, R and Cascinu, S and Bearz, A and ... and FORTIS-M Study Investigators
Annals of Oncology, ISSN 0923-7534, 11/2013, Volume 24, Issue 11, pp. 2875 - 2880
Journal Article
Physics Letters B, ISSN 0370-2693, 2008, Volume 666, Issue 5, pp. 435 - 445
The process p (p) over bar -> gamma + jet + X is studied using 1.0 fb(-1) of data collected by the DO detector at the Fermilab Tevatron p (p) over bar collider... 
ENERGY | QCD | GLUON DISTRIBUTION | ASTRONOMY & ASTROPHYSICS | PHYSICS, NUCLEAR | PHOTOPRODUCTION | PHYSICS, PARTICLES & FIELDS | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences
Journal Article
by Fuchs, Charles S and Shitara, Kohei and Di Bartolomeo, Maria and Lonardi, Sara and Al-Batran, Salah-Eddin and Van Cutsem, Eric and Ilson, David H and Alsina, Maria and Chau, Ian and Lacy, Jill and Ducreux, Michel and Mendez, Guillermo Ariel and Alavez, Alejandro Molina and Takahari, Daisuke and Mansoor, Wasat and Enzinger, Peter C and Gorbounova, Vera and Wainberg, Zev A and Hegewisch-Becker, Susanna and Ferry, David and Lin, Ji and Carlesi, Roberto and Das, Mayukh and Shah, Manish A and Luft, Alexander V and Karaseva, Nina A and Kowalyszyn, Rubén Dario and Hernandez, Carlos Alberto and Csoszi, Tibor and De Vita, Ferdinando and Pfeiffer, Per and Sugimoto, Naotoshi and Kocsis, Judit and Csilla, Andràs and Bodoky, Gyorgy and Garnica Jaliffe, Georgina and Protsenko, Svetlana and Madi, Ayman and Wojcik, Elzbieta and Brenner, Baruch and Folprecht, Gunnar and Sarosiek, Tomasz and Peltola, Katriina Johanna and Bono, Peter and Ayala, Hubert and Aprile, Giuseppe and Gerardo, Cardellino Giovanni and Huitzil Melendez, Fidel David and Falcone, Alfredo and Di Costanzo, Francesco and Tehfe, Moustapha and Mineur, Laurent and García Alfonso, Pilar and Obermannova, Radka and Senellart, Hélène and Petty, Russell and Samuel, Leslie and Acs, Peter Istvan and Hussein, Maen Abdelkarim and Nechaeva, Marina N and Erdkamp, F.L.G and Won, Elizabeth and Bendell, Johanna Chock and Gallego Plazas, Javier and Lorenzen, Sylvie and Melichar, Bohuslav and Escudero, Miguel Angel and Pezet, Denis and Phelip, Jean-Marc and Kaen, Diego Lucas and Reeves, James A. Jr and Longo Muñoz, Federico and Madhusudan, Srinivasan and Barone, Carlo and Fein, Luis Enrique and Gomez Villanueva, Angel and Hebbar, Mohamed and Prausova, Jana and Visa Turmo, Laura and Vidal Barrull, Joana and Yilmaz, Mette Karen Nytoft and Beny, Alex and Van Laarhoven, H.M.W and DiCarlo, Brian Anthony and Esaki, Taito and Fujitani, Kazumasa and Geboes, Karen and Geva, Ravit and Kadowaki, Shigenori and Leong, Stephen and Machida, Nozomu and Raj, Moses Sundar and Ramirez Godinez, Francisco Javier and Ruzsa, Agnes and Ford, Hugo and Lawler, William E and Maisey, Nicolas Robert and Petera, Jiri and Shacham-Shmueli, Einat and Sinapi, Isabelle and ... and RAINFALL Study Group and RAINFALL Study Grp
The Lancet Oncology, ISSN 1470-2045, 03/2019, Volume 20, Issue 3, pp. 420 - 435
VEGF and VEGF receptor 2 (VEGFR-2)-mediated signalling and angiogenesis can contribute to the pathogenesis and progression of gastric cancer. We aimed to... 
EXPOSURE-RESPONSE | MULTICENTER | GASTROESOPHAGEAL JUNCTION | ANGIOGENESIS | ONCOLOGY | BEVACIZUMAB | COMBINATION | CANCER | EXPRESSION | CHEMOTHERAPY | ENDOTHELIAL GROWTH-FACTOR | Adenocarcinoma | Antimitotic agents | Care and treatment | Analysis | Clinical trials | Product development | Metastasis | Antineoplastic agents | Rain and rainfall
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2020, Volume 382, Issue 1, pp. 41 - 50
Journal Article